Back when PIPEDA was being introduced, there was a lot of concern of how that might impede the day-to-day ability of health care practitioners to work together and care for their patients. A lot was done. There was the whole PARTs tool kit. At the end of it, PIPEDA has not been a barrier. Care, with implied consent and all that, has moved forward.
In terms of the work product, our position has been for some time that de-identified data is really important for researchers to look at: prescribing patterns, prescription drug utilization, those types of things. That may have a prescriber's name attached to it but certainly wouldn't have a patient's name attached to it. It is important that you have access to drug utilization information and the national drug prescription utilization database that CIHI maintains that gets information coming in from the provinces on that as well.